Introduction
Electrocardiographic signs of ventricular repolarisation may reflect subclinical myocardial damage. Changes in the ST-T segment [1, 2] and increased QT dispersion [3] have been associated with the risk of coronary heart disease (CHD) and mortality. Thereafter, the orientation of frontal plane T-wave axis (T-axis) has been proposed as a more efficient and reliable measure of ventricular repolarisation abnormality that can be easily and repeatedly evaluated from a standard electrocardiogram [4] in epidemiological settings.
Results on the predictive value of T-axis on cardiovascular disease are sparse and controversial and mainly confined to CHD and mortality. Two studies reported that abnormal frontal or spatial Taxis measured from standard 12-lead electrocardiograms was independently associated with an increased risk of CHD and total mortality in older subjects [5, 6] . The Multiple Risk Factor Intervention Trial found that the change over time in the spatial T-axis was associated with incident CHD [7] . In contrast, the ARIC study failed to show any association between spatial T-axis and incident coronary events [8] . However, no studies have investigated the association between T-axis and other cardiovascular features such as heart failure, atrial fibrillation or stroke.
T-axis is associated with several risk factors [9e11] and with some cardiac abnormalities, such as left ventricular hypertrophy, predictive of such cardiovascular conditions [12] . It has been recently speculated that obesity and hypertension could have a relevant role in the pathogenesis of abnormal T-axis [13] . In addition, later studies showed that abnormal T-wave axis shift is independently associated with the metabolic syndrome [14] , suggesting that a careful electrocardiogram (ECG) recording should be made in subjects with metabolic syndrome to make an early detection of abnormal T-axis in clinical practice.
Recently, an ECG risk equation based on the First National Health and Nutrition Examination Survey (NHANES) cohort was able to correctly assess the risk for CVD death in the Third NHANES cohort [15] . The risk score based on frontal T axis deviation, together with age, sex, heart rate and QT interval, compares favourably with the Framingham risk score alone [15] .
We conducted a prospective analysis among 24,325 subjects recruited within the Moli-sani Study to investigate the following novel hypotheses: 1) deviation from normality of frontal T-axis is associated with risk of heart failure (HF), atrial fibrillation (AF) and stroke in a general population, independently of common risk factors for cardiovascular disease and other ECG abnormalities; 2) markers of sub-clinical inflammation, hs-troponin I and hs-NTproBNP, are biological mediators of the possible associations of frontal T-axis with vascular outcomes. As a secondary aim, we wished to confirm the association of T-axis deviation with CHD or cardiovascular mortality.
Materials and methods

Study population
The Moli-sani Study is an ongoing, prospective, population based, cohort of 24,325 men and women (aged !35 years) living in the Molise region, a southern-central area of Italy. Participants were randomly enrolled from city hall registries between March 2005 and April 2010 by a multistage sampling [16] .
Exclusion criteria were pregnancy at the time of recruitment, lack of understanding or willingness, current poly-traumas or coma, or refusal to sign the informed consent. Thirty percent of subjects refused to participate; these individuals were generally older and had a higher prevalence of cardiovascular disease and cancer.
The Moli-sani study complies with the Declaration of Helsinki and was approved by the Catholic University of Rome ethical committee. All participants provided written informed consent.
Individuals with an incomplete anamnestic questionnaire (n ¼ 235), history of CHD or stroke or unascertained illness (n ¼ 1729), history of HF (n ¼ 143), inferior or anterior myocardial infarction by electrocardiogram (n ¼ 1033 and n ¼ 38 respectively), T-wave axis value missing (n ¼ 195), lost to follow-up (n ¼ 44), or missing information on incident outcomes (n ¼ 10) were also excluded. The final study sample included 21,287 subjects. Participants were asymptomatic for vascular diseases at baseline.
ECG measurements
ECG measures were obtained from the standard 12-lead resting electrocardiogram recorded by Cardiette ® ar2100-view electrocardiograph, which stored electrocardiograms in SCP format. ECGs were then automatically processed by the "University of Glasgow 12-Lead ECG Analysis Algorithm" [17] . Among many features, the Glasgow algorithm provides T-wave frontal axis and MINNESOTA coding -the internationally agreed standard for epidemiological studies and clinical trials [18] . This algorithm has been involved in numerous clinical studies, and is generally regarded as one of the premiere ECG interpretation algorithms within the cardiology community worldwide. T-wave frontal axis was classified as: normal (15 to 
Definition of common risk factors
Hypertension was defined as systolic blood pressure !140 mmHg and/or diastolic blood pressure !90 mmHg, or the use of pharmacological treatment for hypertension. Values of systolic blood pressure !130 and <140 or diastolic blood pressure !85 and <90 were used to define prehypertension. Diabetes was defined as glucose level !126 mg/dl or current antidiabetic treatment, while prediabetes was defined as glucose level !110 and <126 mg/dl.
Subjects were also classified as never-smokers, current smokers or ex-smokers (having stopped for at least 1 year). Education was used as proxy of the socioeconomic status and was based on the highest qualification attained, and was categorized as low (up to lower secondary school; approximately 8 years of study) or high (upper secondary education or higher; approximately >8 years of study).
Physical activity was assessed by using the MOSPA-Q structured, validated questionnaire (24 questions on working time, leisure time and sport participation [19] and expressed as daily energy expenditure in metabolic equivalent task-hours (MET-h/day) [20] . Body mass index (BMI) was calculated as kg/m 2 and then classified as normal (BMI 25), overweight (25 < BMI < 30) or obese (BMI!30).
Blood measurements
Blood samples were obtained between 07:00 and 09:00 from participants who had fasted overnight and had refrained from smoking for at least 6 h. Hemocromocytometric, high sensitivity C reactive protein (CRP), lipids and glucose analyses were performed in the centralized Moli-sani laboratory on fresh samples within three hours from venipuncture [10] . All hemocromocytometric analyses were performed with the same cell counter (Coulter HMX, Beckman-Coulter, IL-Milan, Italy). CRP was measured, by a latex particle-enhanced immunoturbidimetric assay (IL-Coagulation Systems on ACL9000). Inter-and intra-day CV were 5.5% and 4.2%, respectively.
For INFLA-score, the 10-tiles of four biomarker levels (i.e. CRP, white blood cell and platelet counts, granulocyte to lymphocyte ratio) were generated [21] . For all components, higher levels (i.e. >Q6) scored increasing positively, while lower levels got negative scoring. The INFLA-score ranged between À16 and 16.
Serum lipids and glucose were assayed by enzymatic reaction methods using an automatic analyser (ILa350, Instrumentation Laboratory, Milan, Italy). LDL-cholesterol was calculated according to Friedewald.
Highly sensitive troponin I (hsTnI) and NT-proBNP levels were determined in the frame of the BiomarCaRE project [22] on serum samples frozen in liquid nitrogen at baseline. hsTnI concentrations were determined by the ARCHITECT-STAT highly sensitive troponin I immunoassay (Abbott Diagnostics, USA; ARCHITECT-i2000SR).
The limit of detection is 1.9 ng/L with 10% coefficient of variation at a concentration of 5.2 ng/L. NT-proBNP levels were measured on the ELECSYS-2010 using an electrochemiluminescence immunoassay (ECLIA, Roche Diagnostics). The analytical reporting range is 5e35,000 ng/L. The functional assay sensitivity (defined as the lowest concentration detectable with an inter assay CV of 20%) is < 50 ng/L.
Ascertainment of cases
The whole Moli-sani cohort (n ¼ 24,325) was followed-up for HF, AF, CHD, stroke and death for a median of 4.3 years (maximum 6.8 years).
The ascertainment of vital status was carried out through linkage with demographic registers, to identify the date of death. Moreover, death certificates were retrieved; these reported the initial and underlying causes of death and were coded according to the International Classification of Diseases, ninth revision (ICD-9). In-hospital deaths were also checked through regional hospital discharge databases by record linkage to the Moli-sani database.
On 31/12/2011, a total of 575 deaths had occurred among the whole Moli-sani cohort, 102 CVD deaths have been included in the present analysis.
CHD was defined as primary incident cases of fatal and nonfatal events of unstable angina, myocardial infarction, coronary revascularization or both, as well as sudden death for an unspecified cardiac event.
Suspected CHD deaths were identified when death certificates stated (i) ischemic heart disease (ICD-9 included in the range 410e414) as the underlying cause of death; (ii) sudden death (ICD-9798 and 799) as the underlying cause of death; (iii) diabetes (ICD-9250) or arterial hypertension (ICD-9401e405) or other forms of heart disease (ICD-9420e429) as the underlying cause of death, associated with ischemic heart disease (ICD-9410e414) as a secondary cause of death. After linkage with the hospital discharge files, all records reporting ICD-9410e414 and/or reperfusion procedure (ICD-9 36.0e36.9) were considered. The disease was verified when CHD was noted on the clinical records, backed up by information on symptoms at onset and concentrations of cardiac enzymes (troponins). When troponin was not available, ECG data coded according to the Minnesota Code were used [23] . CHD events were validated using procedures of the AHA, WHF, ESC, CDC and NHLBI for epidemiology and clinical research studies [24] .
Suspected stroke deaths were identified when ICD-9430e438 were reported as the underlying, antecedent, or direct cause of death. Fatal stroke was assigned after verification against hospital discharge and clinical records, when possible.
Subjects with suspected stroke were identified on hospital discharge forms by ICD-9430e432, 434, 436e438 or by procedure codes for carotid revascularization (ICD-9 38.12). If clinical documentation was found, the event was validated using the MONICA procedure. However, if during the validation of a stroke, computed tomography or nuclear magnetic resonance revealed a cerebral infarction or haemorrhage, the stroke event was confirmed even if the MONICA criteria were not fulfilled.
Incident HF and AF at follow-up were defined by HF or AF hospitalization or HF or AF death, according to the ICD-9428 and 427.3, respectively. Classification obtained from administrative registers has high specificity and can be used in follow-up studies with HF as an end point [25] . Hospital discharge diagnosis has a positive predictive value of 98.6% for AF [26] and only 0.1% of persistent or intermittent AF are not identified [27] .
Statistical analysis
Main characteristics of the study population are presented as numbers and percentages for categorical variables, or means ± standard deviation (SD) for continuous variables. Analysis of variance was used to identify potential predictors tested for association with abnormalities of T-axis. Several models of adjustment were used (see the footnote of Table 2 
Results
Characteristics of the study population according to frontal T wave axis are illustrated in Table 1 . Borderline or abnormal T-axis was observed in 20.4% and 2.1% of subjects, respectively. Compared to subjects with normal frontal T wave axis, those in the borderline or abnormal group were older, had lower education, higher BMI, and higher prevalence of hypertension and diabetes. The prevalence of other electrocardiographic abnormalities was also higher in the abnormal T-axis group. The number of participants with borderline (abnormal) frontal T wave axis who did not have other ECG abnormalities at baseline was n ¼ 859 (n ¼ 10).
A total of 21,287 Moli-sani participants (mean age 55 ± 11 years, 46% men) were followed for heart disease and mortality for a median of 4.4 years (range Q1-Q3: 3.5e5.3 years; 93,016 personyears). During this time, 270 CHD (1.3%), 400 HF (1.9%), 252 AF (1.2%), 64 stroke (0.3%) and 102 (0.5%) cardiovascular deaths occurred (Table 2) .
T-axis and cardiovascular disease
Participants with borderline (HR ¼ 1.56; 1.19e2.04) or abnormal (HR ¼ 2.87; 1.82e4.53) T-axis had an increased age and sex adjusted relative risk of CHD compared with individuals with normal frontal T wave axis (Table 2) . After further adjustment for smoking habit, physical activity, education, BMI, hypertension, diabetes and personal history of cancer at baseline, the associations were not modified. The inclusion in the model of ECG abnormalities slightly reduced the associations (HR ¼ 1.42; 1.07e1.89 and HR ¼ 2.04; 1.20e3.46 for borderline and abnormal, respectively; Fig. 1) . No associations were found with stroke (Table 2 ; Fig. 1 ). All results did not differ for men and women (p for difference of effect >0.05; data not shown).
T-axis and hospitalized heart failure
Subjects with abnormal T-axis showed a significant increase in the relative risk of heart failure (HR ¼ 2.89; 95% CI ¼ 2.04e4.10, Fig. 1 ).
T-axis and hospitalized atrial fibrillation
Abnormal T-axis was associated with an increase in the relative risk of atrial fibrillation (Table 2 ). However, the association was strongly reduced and it was no longer statistically significant when adjusted for concomitant ECG abnormalities (Table 2, model 2; Fig. 1 ).
T-axis and CVD mortality
Abnormal T-axis was associated with an increased risk of CVD mortality ( Table 2 ). The association was strongly reduced and it was no more statistically significant when adjusted for concomitant ECG abnormalities (Table 2 , model 2).
T-axis and circulating markers of subclinical inflammation and cardiac ischemia
Frontal T wave axis was positively associated with an inflammatory score (including hs-CRP levels, platelet count, with blood cell count and granulocyte/lymphocyte ratio), with troponin I and NT-proBNP levels (Table 1) . Individuals with abnormal T-axis clearly showed higher levels of all these biomarkers (p < 0.001 for all). However, while the inclusion of the inflammation score in the multivariable models did not change the association between Taxis and outcomes (Table 2 , model 3), further adjustment for troponin I (model 4) or NT-proBNP (model 5) determined a reduction of 12.1% or 14.0% and 1.2% or 16.0% of the hazard ratio for CHD and HF, respectively (Table 2) . When the two biomarkers were added simultaneously in the multivariable model 6, the reduction was 24.0 for CHD and 14.8% for HF (Table 2, model 6). However, all the associations remained statistically significant.
Sensitivity analyses
Subgroups analyses were undertaken for each outcome under study. No significant interaction was found either for age groups ( 65 or >65 years, p > 0.26 in models 2 for all outcomes) or for sex (p > 0.18 in models 2 for all outcomes).
Discussion
This study demonstrates that abnormalities of frontal T-axis are associated with an increased risk of coronary heart disease, heart failure, atrial fibrillation and cardiovascular mortality, but not with stroke in a large sample of the Italian adult population. The associations were independent of age, sex and common risk factors for cardiovascular disease, including hypertension and obesity. The associations of T-axis orientation with coronary heart disease and heart failure were still significant after further adjustment for other ECG abnormalities, while those for atrial fibrillation and cardiovascular mortality disappeared.
Data from epidemiological settings showing that T-axis is a predictor of cardiovascular morbidity and mortality are confined to Categorical variables are presented as numbers and percentages; continuous variables (total physical activity, BMI, heart rate, QT dispersion, QRS duration, low-grade inflammation score, troponin I, NT-proBNP) as means ± SD. Means and p values are adjusted for age and sex. a Comparison among normal, borderline and abnormal individuals.
elderly or middle age subjects [6, 7] , or to patients with previous cardiac events [28, 29] or with chronic Chagas' disease [30] . To the best of our knowledge, this is the first time that such studies have been extended to a wide age range of the general adult population and also include associations with HF. T-axis has long been known to provide a global measure of repolarisation abnormalities that have been attributed to ischemic changes in the heart, but the mechanisms underlying ventricular repolarisation are far from being clear [10e12]. We have previously showed that T-axis was strongly associated with inflammation indexes [10] , speculating that T-wave axis abnormalities may allow early identification of subclinical cardiac damage likely to be attributable to a chronic inflammation status. We have now analysed this possible mediation effect by using an inflammatory score of low-grade inflammation [21] that accounts for the possible synergistic effects of plasmatic and cellular biomarkers of inflammation. Again T-axis abnormality was significantly associated with an increased inflammation score. However, the latter did not account even partially for the association between T-axis and the outcomes.
We also observed that T-axis is associated with circulating levels of troponin I and NT-proBNP. These cardiac markers have been Table 2 Hazard ratio (95% confidence intervals) for heart disease and stroke according to T-wave axis orientation. recently associated with the risk of cardiovascular disease in the healthy population [31] . Troponin is a cardiac specific structural protein whose determination in blood is useful for the diagnosis and management of acute coronary syndromes and that may directly reflect various pathophysiological processes, including cardiac myocyte necrosis and apoptosis. The biological mechanism of the relation between natriuretic peptides and cardiovascular risk is not well understood. Natriuretic peptide levels have been reported to increase progressively with increasing numbers of diseased coronary arteries [32] , possibly reflecting increased cardiac expression and release of natriuretic peptides during myocardial ischemia [32] due to elevated ventricular wall stress.
Frontal T-wave axis orientation
These biomarkers attenuated the association between T-axis abnormalities and risk of cardiovascular outcomes both when considered individually in the multivariable model and when added simultaneously. However, the association was still significant, indicating that measuring T-axis can capture more than the risk associated with the two biomarkers.
Strengths and limitations of this study
Major strengths of this study include a large community-based cohort and a prospective design. In addition, further control of all analyses by a wide panel of possible confounding factors, also including other electrocardiographic abnormalities, assures consistency among the observed associations.
The observational nature of our study does not allow for inference of causality. The presence of unknown or residual confounders could not be completely ruled out, although adjustment for a large panel of potential key confounders was performed. One more limitation of the present study is the short duration of the followup and, consequently, the relatively low number of events. However, the dose response and the consistency of the association through the different outcomes evaluated offer reassurance on the reliability of our findings. A further limitation of our approach is the one-time measures of ECG, behavioural and biomedical factors that are unlikely to fully capture exposure over the life course, although this is common in large population-based studies.
Conclusions and perspectives
This study has explored the association of frontal T-wave axis with several cardiac clinical phenotypes, including HF and AF in an adult population free from CVD disease. The value of T-wave axis deviation is already incorporated in the electrocardiogram and it is easy to be understood by clinicians. Electrocardiography still represents the most widely used cardiovascular test in clinical practice. Despite this, physicians rarely take full advantage of the amount of information provided by this simple and almost inexpensive tool. The introduction of digital electrocardiography, currently standard in most Countries, has further widened the diagnostic capabilities of this technique for pharmacological and epidemiological studies, as well as for a preclinical diagnosis of cardiac disease [33] . T-wave axis seems to be an ECG measure useful to better stratify individual risk, as compared with, and in addition to the traditional use of cardiovascular risk factors [14] . A better stratification with an inexpensive tool could allow, in the next future, a more focused and effective preventive intervention in individuals.
In conclusion, our findings suggest the opportunity of using Twave monitoring, which is an easy-to-measure and inexpensive test, as a useful tool for early detection of future adverse healthoutcomes, especially in large population settings.
Conflict of interest
The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript. The funders had no role in study design, collection, analysis, and interpretation of data, in the writing of the report and decision to submit the article for publication. All authors were and are independent from funders.
Financial support
The enrolment phase of the Moli-sani Study was supported by research grants from Pfizer Foundation, the Italian Ministry of University and Research (MIUR, Rome, Italy)eProgramma Triennale di Ricerca, Decreto no.1588 and Instrumentation Laboratory, Milan, Italy. hsTnI and NT-proBNP were determined in the frame of the BiomarCaRE Project, funded by the European Union Seventh Framework Programme (HEALTH-F2-2011-278913) . Fig. 1 . Association of T-wave axis orientation (normal, borderline, abnormal) with risk of heart failure, atrial fibrillation, CHD and stroke. Hazard ratios are from Model 2 in Table 2 . Marialaura Bonaccio is supported by a Fondazione Umberto Veronesi Fellowship.
